Clinical trial of 20% Mat lippia (bucan) topical ointment for cutaneous leishmaniasis; a preliminary trial

Journal of Pakistan Association of Dermatologists

Volumn 15, Issue 2, 2005, Pages 108-112

  Soomro, Farooq Rahman ^a   Pathan, Ghulam Murtaza ^a   Abbasi, Parvez ^a   Bhatti, Nuzhat Seema ^a   Hussain, Javeed ^a   Sarwar, Ghulam ^a   Bhutto, Abdul Manan ^a   Yoshihisahashiguchi, ^b  

^a Chandka Medical College Hospital Shaheed Muhtarma Benazir Bhutto Medical University Larkana   (Pakistan)

^b KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Leishmaniasis; Mat lippia ointment

Indexed keywords

MAT LIPPIA EXTRACT; PETROLATUM; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG FORMULATION; DRUG MECHANISM; FEMALE; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICINAL PLANT; NATIVE SPECIES; PLANT LEAF; SKIN LEISHMANIASIS; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 33749074909     PISSN: 15609014     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. The Leishmaniasis. Report of a WHO Expert Committee. Technical Report Series No. 701. Geneva: WHO; 1984. p. 1-140.
2. Control of the Leishmaniasis. Report of a WHO Expert Committee. Technical Report Series No. 793. Geneva: WHO; 1990. p. 1-158.
3. Bosan AH, Amanullah M, Dil AS. The efficacy of intralesional treatment of cutaneous leishmaniasis with glucantime. Pak J Med Res 2002; 41: 54-7.
4. Pathan GM, Soomro FR. Cutaneous leishmaniasis in a village of mountainous belt of Larkana District. J Pak Assoc Dermatol 2001; 11: 16-9.
5. Soomro FR, Pathan GM, Soomro RA. The patterns of cutaneous leishmaniasis and differential diagnosis of misdiagnosed cases in Larkana Region. J Pak Assoc Dermatol 2002; 12: 77-82.
6. Soomro FR, Pathan GM, Bhutto AM et al. A preliminary survey on cutaneous leishmaniasis at village Gaibi Dero Larkana District, Sindh, Pakistan. Studies on New and Old World leishmaniases and their transmission, with particular reference to Ecuador, Argentina and Pakistan. Research Report Series No. 7. Kochi: Kochi Medical School; 2004.
7. Khan IK, Khan MA. Managing cutaneous leishmaniasis from Peru to Pakistan. J Pak Assoc Dermatol 2000; 10: 5-15.
8. Ravishankar, B, Makwana HJ, Nair RB, Vijayan NP. Pharmacological Studies on Lippia nodiflora mich. Part A-Petroleum, ether and chloroform extracts. J Res Auryveda Sinddha 1980; 10: 141-52.
9. Ajmal M, Bhutto AH. Antimicrobial activity of non-alkaloidal constituents of Lippia nodiflora (Thesis). Karachi: Institute of Pharmacy: University of Sindh; 2002.
10. Akhter FM. Chemical and biological investigation of medicinal herbs. Karachi: Department of Pharmacognosy, Faculty of Pharmacy, University of Karachi; 1993.
11. Elakouich SD, Steven KL. Volatile constitute of Lippia-nodiflora. J Nat Products 1985; 58: 504-6.
12. Joshi. BC, Parishad V. Chemical examination of Lippia nodiflora. J Sci Industr Res 1959; 18: 527-37.
13. Monforte, MT, Ragus S, Trovato A, Foresteieri AM. Antiinflammatory, analgesic and antipyretic activity in rodents of plant extracts used in African Medicine. Photother Res 1996; 10: 100-6.
14. nd edn. Butterworth: Cambridge Tropical Health Technology; 1987.
15. nd impression. Karachi: Hamdard Foundation; 1970.
16. Dynmack W, ed. Pharmacographia India. Karachi: Hamdard Foundation; 1972. 57-58.
17. Bhandari MM. Flora of the Indian Desert. Jodhupur: Scientific Publishers; 1978.
18. th edition. Tehran: Department of Pharmacognosy, College of Pharmacy Tehran University of Medical Sciences; 1992. Iran 889.
19. Ashraf TA, Mohammad L, Salama F, Osman M. Phenolic compounds from Lippia nodiflora. Mansoura J Pharma Sci 1995; 11: 256-65.